BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 27458852)

  • 1. Role of oxidative stress and insulin resistance in disease severity of non-alcoholic fatty liver disease.
    Köroğlu E; Canbakan B; Atay K; Hatemi İ; Tuncer M; Dobrucalı A; Sonsuz A; Gültepe I; Şentürk H
    Turk J Gastroenterol; 2016 Jul; 27(4):361-6. PubMed ID: 27458852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis and Disease Severity is Associated with Insulin Resistance in Non-alcoholic Fatty Liver Disease.
    Atay K; Canbakan B; Koroglu E; Hatemi I; Canbakan M; Kepil N; Tuncer M; Senturk H
    Acta Gastroenterol Belg; 2017; 80(2):271-277. PubMed ID: 29560693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gamma glutamyl transferase is an independent determinant for the association of insulin resistance with nonalcoholic fatty liver disease in Bangladeshi adults: Association of GGT and HOMA-IR with NAFLD.
    Hossain IA; Rahman Shah MM; Rahman MK; Ali L
    Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S25-9. PubMed ID: 26482965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Study of Serum Homocysteine and Non-Alcoholic Fatty Liver Disease in Euglycemic Patients.
    Hu Y; Liu J; Dong X; Xu Y; Leng S; Wang G
    Med Sci Monit; 2016 Nov; 22():4146-4151. PubMed ID: 27803497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress biomarkers in the serum and plasma of patients with non-alcoholic fatty liver disease (NAFLD). Can plasma AGE be a marker of NAFLD? Oxidative stress biomarkers in NAFLD patients.
    Świderska M; Maciejczyk M; Zalewska A; Pogorzelska J; Flisiak R; Chabowski A
    Free Radic Res; 2019 Aug; 53(8):841-850. PubMed ID: 31234658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of pro-inflammatory cytokines, adipokines & oxidative stress with insulin resistance & non-alcoholic fatty liver disease.
    Kumar R; Prakash S; Chhabra S; Singla V; Madan K; Gupta SD; Panda SK; Khanal S; Acharya SK
    Indian J Med Res; 2012 Aug; 136(2):229-36. PubMed ID: 22960889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptin in nonalcoholic fatty liver disease.
    Canbakan B; Tahan V; Balci H; Hatemi I; Erer B; Ozbay G; Sut N; Hacibekiroglu M; Imeryuz N; Senturk H
    Ann Hepatol; 2008; 7(3):249-54. PubMed ID: 18753993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of steatosis and insulin resistance in patients with chronic hepatitis B compared with chronic hepatitis C and non-alcoholic fatty liver disease.
    Pais R; Rusu E; Zilisteanu D; Circiumaru A; Micu L; Voiculescu M; Poynard T; Ratziu V
    Eur J Intern Med; 2015 Jan; 26(1):30-6. PubMed ID: 25553983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Plasma Levels of Asymmetric Dimethylarginine in Nonalcoholic Fatty Liver Disease: Relation With Insulin Resistance, Inflammation, and Liver Histology.
    Boga S; Alkim H; Koksal AR; Bayram M; Ozguven MB; Ergun M; Neijmann ST; Ozgon G; Alkim C
    J Investig Med; 2015 Oct; 63(7):871-7. PubMed ID: 26244718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children.
    El-Karaksy HM; El-Raziky MS; Fouad HM; Anwar GM; El-Mougy FM; El-Koofy NM; El-Hennawy AM
    Diabetes Metab Syndr; 2015; 9(2):114-9. PubMed ID: 25470627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of combined low-dose spironolactone plus vitamin E vs vitamin E monotherapy on insulin resistance, non-invasive indices of steatosis and fibrosis, and adipokine levels in non-alcoholic fatty liver disease: a randomized controlled trial.
    Polyzos SA; Kountouras J; Mantzoros CS; Polymerou V; Katsinelos P
    Diabetes Obes Metab; 2017 Dec; 19(12):1805-1809. PubMed ID: 28452101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.
    Yang KC; Hung HF; Lu CW; Chang HH; Lee LT; Huang KC
    Sci Rep; 2016 Jun; 6():27034. PubMed ID: 27246655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of DASH diet on weight loss and metabolic status in adults with non-alcoholic fatty liver disease: a randomized clinical trial.
    Razavi Zade M; Telkabadi MH; Bahmani F; Salehi B; Farshbaf S; Asemi Z
    Liver Int; 2016 Apr; 36(4):563-71. PubMed ID: 26503843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonalcoholic Steatohepatitis (NASH) Is Associated with a Decline in Pancreatic Beta Cell (β-Cell) Function.
    Siddiqui MS; Cheang KL; Luketic VA; Boyett S; Idowu MO; Patidar K; Puri P; Matherly S; Stravitz RT; Sterling RK; Sanyal AJ
    Dig Dis Sci; 2015 Aug; 60(8):2529-37. PubMed ID: 25784075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum paraoxonase activity and oxidative stress and their relationship with obesity-related metabolic syndrome and non-alcoholic fatty liver disease in obese children and adolescents.
    Torun E; Gökçe S; Ozgen İT; Aydın S; Cesur Y
    J Pediatr Endocrinol Metab; 2014 Jul; 27(7-8):667-75. PubMed ID: 24706428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic steatohepatitis associated with metabolic syndrome: relationship to insulin resistance and liver histology.
    Jung KY; Cho SY; Kim HJ; Kim SB; Song IH
    J Clin Gastroenterol; 2014; 48(10):883-8. PubMed ID: 24440936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leptin, free leptin index, insulin resistance and liver fibrosis in children with non-alcoholic fatty liver disease.
    Nobili V; Manco M; Ciampalini P; Diciommo V; Devito R; Piemonte F; Comparcola D; Guidi R; Marcellini M
    Eur J Endocrinol; 2006 Nov; 155(5):735-43. PubMed ID: 17062890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of vitamin E treatment on peroxisome proliferator-activated receptor-alpha expression and insulin resistance in patients with non-alcoholic steatohepatitis: results of a pilot study.
    Yakaryilmaz F; Guliter S; Savas B; Erdem O; Ersoy R; Erden E; Akyol G; Bozkaya H; Ozenirler S
    Intern Med J; 2007 Apr; 37(4):229-35. PubMed ID: 17388862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adipocytokines and cytokeratin-18 in patients with nonalcoholic fatty liver disease: Introduction of CHA index.
    Polyzos SA; Kountouras J; Papatheodorou A; Katsiki E; Patsiaoura K; Zafeiriadou E; Papadopoulou E; Zavos C; Terpos E
    Ann Hepatol; 2013; 12(5):749-57. PubMed ID: 24067262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, biochemical and histological correlations in a group of non-drinker subjects with non-alcoholic fatty liver disease.
    Canbakan B; Senturk H; Tahan V; Hatemi I; Balci H; Toptas T; Sonsuz A; Velet M; Aydin S; Dirican A; Ozgulle S; Ozbay G
    Acta Gastroenterol Belg; 2007; 70(3):277-84. PubMed ID: 18074737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.